Steris reported $97.5M in Ordinary Share Capital for its fiscal quarter ending in September of 2026.





Ordinary Share Capital Change Date
3M USD 516.73M 1.01M Sep/2026
Accuray USD 100K 1000 Sep/2024
Baxter International USD 517M 549K Jun/2026
Becton, Dickinson and Co. USD 272.39M 98.21M Sep/2026
Boston Scientific USD 1.48B 2.66M Dec/2025
CONMED USD 29.87M 118K Sep/2026
Cooper Companies USD 190.1M 5.01M Jun/2026
Dexcom USD 377.4M 8.5M Jun/2026
Ecolab USD 280.33M 1.07M Sep/2026
Edwards Lifesciences USD 576.6M 400K Jun/2026
Fortive USD 298.1M 4.5M Sep/2026
Getinge SEK 272.37M 136.37M Jun/2026
Globus Medical USD 132.66M 1.59M Sep/2026
Haemonetics USD 45.52M 53K Sep/2026
Idexx Laboratories USD 78.78M 93K Sep/2026
Inogen USD 23K 0 Dec/2023
Insulet USD 69.37M 16K Sep/2026
Integra LifeSciences USD 77.78M 39K Jun/2026
Intuitive Surgical USD 353.28M 885K Sep/2026
J&J USD 2.41B 1.64M Jun/2026
Olympus JPY 1.06B 32.89K Sep/2026
Orthofix International USD 39.83M 315K Dec/2025
Owens Minor USD 76.39M 911K Dec/2025
ResMed USD 145.06M 45.78M Jun/2026
Steris USD 97.5M 575K Sep/2026
Stryker USD 383.4M 416K Jun/2026
Tandem Diabetes Care USD 69.76M 217K Sep/2026
Teleflex USD 42.37M 1.89M Jun/2026
Thermo Fisher Scientific USD 369.75M 1.88M Sep/2026
Zimmer Biomet Holdings USD 190.1M 3.3M Sep/2026